{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:28:11Z","timestamp":1780615691161,"version":"3.54.1"},"reference-count":224,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ijbiomac.2021.10.015","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T01:10:56Z","timestamp":1634260256000},"page":"1040-1057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis?"],"prefix":"10.1016","volume":"192","author":[{"given":"Bhargab","family":"Kalita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Saviola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashis K.","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ijbiomac.2021.10.015_bb0005","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMe2002387","article-title":"Covid-19 - navigating the uncharted","volume":"382","author":"Fauci","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0010","author":"WHO"},{"issue":"7798","key":"10.1016\/j.ijbiomac.2021.10.015_bb0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0020","author":"Ma"},{"issue":"6540","key":"10.1016\/j.ijbiomac.2021.10.015_bb0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.abf8003","article-title":"Timing the SARS-CoV-2 index case in Hubei province","volume":"372","author":"Pekar","year":"2021","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.10.015_bb0030","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMp2000929","article-title":"A novel coronavirus emerging in China - key questions for impact assessment","volume":"382","author":"Munster","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijsu.2020.02.034","article-title":"World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)","volume":"76","author":"Sohrabi","year":"2020","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0040","author":"WHO"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0045","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0050","author":"WHO"},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.10.015_bb0055","first-page":"1061","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan,China","volume":"323","author":"Wang","year":"2020"},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.10.015_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100618","article-title":"COVID-19 and multiorgan response","volume":"45","author":"Zaim","year":"2020","journal-title":"Curr. Probl. Cardiol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.10.015_bb0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/a-1217-2397","article-title":"Coronavirus Disease-2019 (COVID-19): an updated review","volume":"70","author":"Rudrapal","year":"2020","journal-title":"Drug Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.10.015_bb0070","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb0075","first-page":"844","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020"},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb0080","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/CIRCRESAHA.120.317447","article-title":"The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications","volume":"127","author":"McFadyen","year":"2020","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.10.015_bb0085","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.cell.2015.11.031","article-title":"A new Golden age of natural products drug discovery","volume":"163","author":"Shen","year":"2015","journal-title":"Cell"},{"issue":"19\u201320","key":"10.1016\/j.ijbiomac.2021.10.015_bb0090","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.drudis.2008.07.004","article-title":"Natural products in drug discovery","volume":"13","author":"Harvey","year":"2008","journal-title":"Drug Discov. Today"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2021.10.015_bb0095","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0167-4838(99)00268-X","article-title":"Snake venom proteases affecting hemostasis and thrombosis","volume":"1477","author":"Matsui","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"28","key":"10.1016\/j.ijbiomac.2021.10.015_bb0100","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.2174\/138161207782023775","article-title":"Snake venom components affecting blood coagulation and the vascular system: structural similarities and marked diversity","volume":"13","author":"Yamazaki","year":"2007","journal-title":"Curr. Pharm. Des."},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.10.015_bb0105","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1517\/14712598.2011.621940","article-title":"Venoms as a platform for human drugs: translating toxins into therapeutics","volume":"11","author":"King","year":"2011","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb0110","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.toxicon.2011.03.017","article-title":"From snake venom toxins to therapeutics\u2013cardiovascular examples","volume":"59","author":"Koh","year":"2012","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/15569543.2014.942040","article-title":"Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads","volume":"33","author":"Saviola","year":"2014","journal-title":"Toxin Rev."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.10.015_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11100564","article-title":"Snake venoms in drug discovery: valuable therapeutic tools for life saving","volume":"11","author":"Mohamed Abd El-Aziz","year":"2019","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb0125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.drudis.2020.12.021","article-title":"From venom to drugs: a review and critical analysis of indian snake venom toxins envisaged as anticancer drug prototypes","volume":"26","author":"Kalita","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"10234","key":"10.1016\/j.ijbiomac.2021.10.015_bb0130","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.10.015_bb0135","first-page":"845","article-title":"How I treat disseminated intravascular coagulation, blood, the journal of the american society of","volume":"131","author":"Levi","year":"2018","journal-title":"Hematology"},{"issue":"19","key":"10.1016\/j.ijbiomac.2021.10.015_bb0140","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/eurheartj\/ehaa254","article-title":"Acute pulmonary embolism and COVID-19 pneumonia: a random association?","volume":"41","author":"Danzi","year":"2020","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.ijbiomac.2021.10.015_bb0145","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0155","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.120.047430","article-title":"Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence","volume":"142","author":"Poissy","year":"2020","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.10.015_bb0160","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.1148\/radiol.2020201561","article-title":"Acute pulmonary embolism in patients with COVID-19 at CT angiography and relationship to D-dimer levels","volume":"296","author":"L\u00e9onard-Lorant","year":"2020","journal-title":"Radiology"},{"issue":"20","key":"10.1016\/j.ijbiomac.2021.10.015_bb0165","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2009787","article-title":"Large-vessel stroke as a presenting feature of Covid-19 in the young","volume":"382","author":"Oxley","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.10.015_bb0170","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/jth.14854","article-title":"The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome","volume":"18","author":"Ranucci","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.10.015_bb0175","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb0180","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0185","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/22221751.2020.1741327","article-title":"Clinical observation and management of COVID-19 patients","volume":"9","author":"Li","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0190","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/22221751.2020.1746199","article-title":"Hypothesis for potential pathogenesis of SARS-CoV-2 infection\u2013a review of immune changes in patients with viral pneumonia","volume":"9","author":"Lin","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0195","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11684-020-0767-8","article-title":"Coronavirus disease 2019 (COVID-19): a clinical update","volume":"14","author":"Zhou","year":"2020","journal-title":"Front. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.10.015_bb0200","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2174\/138920111798281171","article-title":"Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome","volume":"12","author":"Sebag","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.10.015_bb0205","first-page":"L514","article-title":"Protein C and thrombomodulin in human acute lung injury, american journal of physiology-lung cellular and molecular","volume":"285","author":"Ware","year":"2003","journal-title":"Physiology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.10.015_bb0210","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000453002","article-title":"Immunothrombosis in acute respiratory distress syndrome: cross talks between inflammation and coagulation","volume":"93","author":"Frantzeskaki","year":"2017","journal-title":"Respiration"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.10.015_bb0215","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1358863X20932640","article-title":"COVID\u201319-associated coagulopathy: an exploration of mechanisms","volume":"25","author":"Colling","year":"2020","journal-title":"Vasc. Med."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.10.015_bb0220","first-page":"681","article-title":"Pulmonary and cardiac pathology in african american patients with COVID-19: an autopsy series from New Orleans, the lancet","volume":"8","author":"Fox","year":"2020","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.10.015_bb0225","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.10.015_bb0230","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1172\/JCI124804","article-title":"ENTPD-1 disrupts inflammasome IL-1\u03b2\u2013driven venous thrombosis","volume":"129","author":"Yadav","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-09801-x","article-title":"Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome","volume":"10","author":"Ali","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0240","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fimmu.2012.00385","article-title":"The emerging role of neutrophils in thrombosis\u2014the journey of TF through NETs","volume":"3","author":"Kambas","year":"2012","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.10.015_bb0245","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3390\/jcm8122072","article-title":"Interleukin-1\u03b2 mediates arterial thrombus formation via NET-associated tissue factor","volume":"8","author":"Liberale","year":"2019","journal-title":"J. Clin. Med."},{"issue":"20","key":"10.1016\/j.ijbiomac.2021.10.015_bb0250","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2018-10-862243","article-title":"Neutrophils: back in the thrombosis spotlight","volume":"133","author":"Noubouossie","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.10.015_bb0255","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/ATVBAHA.119.312463","article-title":"Neutrophil extracellular traps: villains and targets in arterial, venous, and cancer-associated thrombosis","volume":"39","author":"Th\u00e5lin","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.10.015_bb0260","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0265","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s11239-020-02324-z","article-title":"Neutrophil extracellular traps and thrombosis in COVID-19","volume":"51","author":"Zuo","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0270","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2004.09.106","article-title":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine","volume":"324","author":"He","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"20","key":"10.1016\/j.ijbiomac.2021.10.015_bb0275","doi-asserted-by":"crossref","first-page":"11429","DOI":"10.1128\/JVI.78.20.11429-11433.2004","article-title":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2","volume":"78","author":"Li","year":"2004","journal-title":"J. Virol."},{"issue":"6965","key":"10.1016\/j.ijbiomac.2021.10.015_bb0280","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb0285","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbrc.2003.11.054","article-title":"The SARS-CoV S glycoprotein: expression and functional characterization","volume":"312","author":"Xiao","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0290","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"6483","key":"10.1016\/j.ijbiomac.2021.10.015_bb0295","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.10.015_bb0300","first-page":"288","article-title":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","volume":"210","author":"He","year":"2006"},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.10.015_bb0305","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","article-title":"Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia","volume":"2","author":"McGonagle","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0310","series-title":"Intravascular coagulation associated with the adult respiratory distress syndrome","author":"Bone","year":"1976"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0315","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3501373","article-title":"A pathophysiologic approach to biomarkers in acute respiratory distress syndrome","volume":"2016","author":"Blondonnet","year":"2016","journal-title":"Dis. Markers"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.10.015_bb0320","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0272-5231(05)70158-1","article-title":"Pulmonary pathology of acute respiratory distress syndrome","volume":"21","author":"Tomashefski","year":"2000","journal-title":"Clin. Chest Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0325","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00003246-198802000-00002","article-title":"Pulmonary microthrombosis in severe adult respiratory distress syndrome","volume":"16","author":"Vesconi","year":"1988","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.10.015_bb0330","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1358863X20932640","article-title":"COVID\u201319-associated coagulopathy: an exploration of mechanisms","volume":"25","author":"Colling","year":"2020","journal-title":"Vasc. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0335","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0340","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1538-7836.2009.03368.x","article-title":"The many faces of tissue factor","volume":"7","author":"Mackman","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.10.015_bb0345","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1160\/TH14-01-0053","article-title":"The coagulation system and its function in early immune defense","volume":"112","author":"van der Poll","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.10.015_bb0350","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98178","article-title":"Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury","volume":"3","author":"Lefran\u00e7ais","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0355","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jth.12047","article-title":"Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome","volume":"11","author":"Glas","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101092","article-title":"Dissecting lipid metabolism alterations in SARS-CoV-2","volume":"82","author":"Casari","year":"2021","journal-title":"Prog. Lipid Res."},{"issue":"5716","key":"10.1016\/j.ijbiomac.2021.10.015_bb0365","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/279799a0","article-title":"The role of platelet-activating factor in platelet aggregation","volume":"279","author":"Chignard","year":"1979","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.10.015_bb0370","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/BF02536541","article-title":"Role of platelet-activating factor in aggregation of leukocytes and platelets in cerebral ischemia","volume":"26","author":"Uchiyama","year":"1991","journal-title":"Lipids"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.10.015_bb0375","volume":"18","author":"Abdol Razak","year":"2017"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0380","first-page":"24","article-title":"Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones","volume":"16","author":"Elaskalani","year":"2018"},{"issue":"25","key":"10.1016\/j.ijbiomac.2021.10.015_bb0385","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1182\/blood-2008-07-171629","article-title":"Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates","volume":"113","author":"Yost","year":"2009","journal-title":"Blood"},{"issue":"36","key":"10.1016\/j.ijbiomac.2021.10.015_bb0390","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb0395","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ajh.2830190404","article-title":"Role of arachidonic acid metabolism in human platelet activation and irreversible aggregation","volume":"19","author":"Rao","year":"1985","journal-title":"Am. J. Hematol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.10.015_bb0400","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.10.015_bb0405","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.10.015_bb0410","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102925","article-title":"Vascular occlusion by neutrophil extracellular traps in COVID-19","volume":"58","author":"Leppkes","year":"2020","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.10.015_bb0420","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0425","article-title":"Anticoagulation in COVID-19: current concepts and controversies","author":"Chandra","year":"2021","journal-title":"Postgrad. Med. J."},{"issue":"06","key":"10.1016\/j.ijbiomac.2021.10.015_bb0430","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1055\/s-0040-1710019","article-title":"Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines","volume":"120","author":"Zhai","year":"2020","journal-title":"Thromb. Haemost."},{"issue":"23","key":"10.1016\/j.ijbiomac.2021.10.015_bb0435","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0440","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620938149","article-title":"COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation","volume":"26","author":"Miesbach","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0445","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620960797","article-title":"The use of therapeutic-dose anticoagulation and its effect on mortality in patients with COVID-19: a systematic review","volume":"26","author":"Wijaya","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0450","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ajem.2021.01.016","article-title":"Effect of antiplatelet treatments on patients with COVID-19 infection: a systematic review and meta-analysis","volume":"43","author":"Wang","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0455","series-title":"Understanding Biological Roles of Venoms Among the Caenophidia: The Importance of Rear-fanged Snakes","author":"Mackessy","year":"2016"},{"issue":"4\u20135","key":"10.1016\/j.ijbiomac.2021.10.015_bb0460","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000092420","article-title":"Hemextin AB complex\u2013a snake venom anticoagulant protein complex that inhibits factor VIIa activity","volume":"34","author":"Banerjee","year":"2005","journal-title":"Pathophysiol. Haemost. Thromb."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.10.015_bb0465","first-page":"958","article-title":"Binding of a Naja naja venom acidic phospholipase A2 cognate complex to membrane-bound vimentin of rat L6 cells: implications in cobra venom-induced cytotoxicity","volume":"1861","author":"Dutta","year":"2019"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0470","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.toxicon.2014.06.016","article-title":"Pharmacological properties and pathophysiological significance of a kunitz-type protease inhibitor (Rusvikunin-II) and its protein complex (Rusvikunin complex) purified from Daboia russelii russelii venom","volume":"89","author":"Mukherjee","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0475","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijbiomac.2014.02.058","article-title":"Characterization of a kunitz-type protease inhibitor peptide (Rusvikunin) purified from Daboia russelii russelii venom","volume":"67","author":"Mukherjee","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0480","first-page":"1","article-title":"Recent advances in snake venom proteomics research in India: a new horizon to decipher the geographical variation in venom proteome composition and exploration of candidate drug prototypes","author":"Kalita","year":"2019","journal-title":"J. Proteins Proteomics"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.10.015_bb0485","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/14789450.2020.1778471","article-title":"Mass spectrometric analysis to unravel the venom proteome composition of indian snakes: opening new avenues in clinical research","volume":"17","author":"Chanda","year":"2020","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0490","first-page":"1132","article-title":"From animal poisons and venoms to medicines: achievements,challenges and perspectives in drug discovery","volume":"11","author":"Bordon","year":"2020"},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.10.015_bb0495","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.toxicon.2005.02.030","article-title":"Snake venoms and coagulopathy","volume":"45","author":"White","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0500","first-page":"1","author":"Alvarez-Flores","year":"2016"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0505","first-page":"1","article-title":"A brief appraisal on Russell\u2019s viper venom (Daboia russelii russelii) proteinases","author":"Thakur","year":"2015","journal-title":"Snake Venoms"},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.10.015_bb0510","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1538-7836.2005.01527.x","article-title":"Molecular models of the procoagulant factor VIIIa\u2013factor IXa complex","volume":"3","author":"Autin","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153770","article-title":"Daboxin P, a major phospholipase A2 Enzyme from the Indian Daboia russelii russelii Venom Targets Factor X and Factor Xa for Its Anticoagulant Activity","volume":"11","author":"Sharma","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0520","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijbiomac.2017.04.018","article-title":"Purification and characterization of cc-lec, C-type lactose-binding lectin: a platelet aggregation and blood-clotting inhibitor from Cerastes cerastes venom","volume":"102","author":"Samah","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0525","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.toxicon.2020.09.009","article-title":"Inhibition of platelet aggregation and blood coagulation by a P-III class metalloproteinase purified from Naja atra venom","volume":"187","author":"Sun","year":"2020","journal-title":"Toxicon"},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.10.015_bb0530","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1055\/s-0038-1669785","article-title":"The first intrinsic tenase complex inhibitor with serine protease structure offers a new perspective in anticoagulant therapy","volume":"118","author":"Latinovi\u0107","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0535","doi-asserted-by":"crossref","first-page":"32036","DOI":"10.1038\/srep32036","article-title":"Exactin: a specific inhibitor of factor X activation by extrinsic tenase complex from the venom of Hemachatus haemachatus","volume":"6","author":"Girish","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0540","doi-asserted-by":"crossref","first-page":"25935","DOI":"10.1038\/srep25935","article-title":"Ringhalexin from Hemachatus haemachatus: a novel inhibitor of extrinsic tenase complex","volume":"6","author":"Barnwal","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0545","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/jth.12217","article-title":"The transition of prothrombin to thrombin","volume":"11","author":"Krishnaswamy","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.10.015_bb0550","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22219","article-title":"Antiplatelet and anticoagulant activities of two phospholipase A2s purified from Cerastes cerastes venom: structure-function relationship","volume":"32","author":"Fatah","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.10.015_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101334","article-title":"Two acidic, anticoagulant PLA2 isoenzymes purified from the venom of monocled cobra Naja kaouthia exhibit different potency to inhibit thrombin and factor xa via phospholipids independent, non-enzymatic mechanism","volume":"9","author":"Mukherjee","year":"2014","journal-title":"PloS one"},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.10.015_bb0560","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.toxicon.2011.02.018","article-title":"An acidic phospholipase A2 (RVVA-PLA2-I) purified from Daboia russelli venom exerts its anticoagulant activity by enzymatic hydrolysis of plasma phospholipids and by non-enzymatic inhibition of factor xa in a phospholipids\/Ca2+ independent manner","volume":"57","author":"Saikia","year":"2011","journal-title":"Toxicon"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.10.015_bb0565","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.thromres.2014.09.009","article-title":"A new C-type lectin (RVsnaclec) purified from venom of Daboia russelii russelii shows anticoagulant activity via inhibition of FXa and concentration-dependent differential response to platelets in a Ca2+-independent manner","volume":"134","author":"Mukherjee","year":"2014","journal-title":"Thromb. Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.10.015_bb0570","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/bip.22078","article-title":"Ca2+-induced binding of anticoagulation factor II from the venom of Agkistrodon acutus with factor IX","volume":"97","author":"Shen","year":"2012","journal-title":"Biopolymers"},{"issue":"7\u20138","key":"10.1016\/j.ijbiomac.2021.10.015_bb0575","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.toxicon.2012.03.006","article-title":"Anticoagulation factor I, a snaclec (snake C-type lectin) from Agkistrodon acutus venom binds to FIX as well as FX: Ca2+ induced binding data","volume":"59","author":"Zhang","year":"2012","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0580","first-page":"1","article-title":"A novel direct factor xa inhibitory peptide with anti-platelet aggregation activity from Agkistrodon acutus venom hydrolysates","volume":"5","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0585","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.biochi.2014.07.006","article-title":"A new peptide (Ruviprase) purified from the venom of Daboia russelii russelii shows potent anticoagulant activity via non-enzymatic inhibition of thrombin and factor Xa","volume":"105","author":"Thakur","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0590","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biochi.2014.12.020","article-title":"Anticoagulant mechanism and platelet deaggregation property of a non-cytotoxic, acidic phospholipase A2 purified from indian cobra (Naja naja) venom: inhibition of anticoagulant activity by low molecular weight heparin","volume":"110","author":"Dutta","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0595","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.toxicon.2016.05.007","article-title":"Exploiting the antithrombotic effect of the (pro) thrombin inhibitor bothrojaracin","volume":"119","author":"Assafim","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0600","series-title":"Seminars in thrombosis and hemostasis","first-page":"003","article-title":"An overview of the structure and function of thrombin","author":"Davie","year":"2006"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0605","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biochi.2013.11.026","article-title":"A major phospholipase A2 from Daboia russelii russelii venom shows potent anticoagulant action via thrombin inhibition and binding with plasma phospholipids","volume":"99","author":"Mukherjee","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0610","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.toxicon.2013.10.001","article-title":"Mechanism of in vivo anticoagulant and haemolytic activity by a neutral phospholipase A2 purified from Daboia russelii russelii venom: correlation with clinical manifestations in Russell's viper envenomed patients","volume":"76","author":"Saikia","year":"2013","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0615","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cbpb.2011.10.002","article-title":"Biochemical and enzymatic characterization of BpMP-I, a fibrinogenolytic metalloproteinase isolated from Bothropoides pauloensis snake venom","volume":"161","author":"de Souza","year":"2012","journal-title":"Comp. Biochem. Physiol. B: Biochem. Mol. Biol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.10.015_bb0620","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.toxicon.2012.08.017","article-title":"Isolation and characterization of moojenin, an acid-active, anticoagulant metalloproteinase from Bothrops moojeni venom","volume":"60","author":"de Morais","year":"2012","journal-title":"Toxicon"},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.10.015_bb0625","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.toxicon.2010.02.014","article-title":"Bhalternin: functional and structural characterization of a new thrombin-like enzyme from Bothrops alternatus snake venom","volume":"55","author":"Costa","year":"2010","journal-title":"Toxicon"},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.10.015_bb0630","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1016\/j.bbagen.2013.02.007","article-title":"Biochemical and pharmacological properties of a new thrombin-like serine protease (Russelobin) from the venom of Russell's viper (Daboia russelii russelii) and assessment of its therapeutic potential","volume":"1830","author":"Mukherjee","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0635","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pep.2014.04.007","article-title":"Purification and partial characterization of a novel fibrinogenase from the venom of Deinagkistrodon acutus: inhibition of platelet aggregation","volume":"99","author":"Wang","year":"2014","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0640","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.10.015_bb0645","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/jth.14848","article-title":"Thrombocytopenia and its association with mortality in patients with COVID-19","volume":"18","author":"Yang","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.10.015_bb0650","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11239-020-02318-x","article-title":"COVID-19 associated coagulopathy in critically ill patients: a hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis","volume":"51","author":"Fan","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"issue":"02","key":"10.1016\/j.ijbiomac.2021.10.015_bb0655","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1160\/TH13-06-0490","article-title":"Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis","volume":"112","author":"Lei","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0660","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.toxicon.2013.01.001","article-title":"Identification of \u03b12\u03b21 integrin inhibitor VP-i with anti-platelet properties in the venom of Vipera palaestinae","volume":"64","author":"Arlinghaus","year":"2013","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0665","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/toxins12010011","article-title":"A novel \u03b1IIb\u03b23 antagonist from snake venom prevents thrombosis without causing bleeding","volume":"12","author":"Kuo","year":"2020","journal-title":"Toxins"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.10.015_bb0670","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s10930-020-09915-y","article-title":"Isolation and functional identification of an antiplatelet RGD-containing disintegrin from Cerastes cerastes venom","volume":"39","author":"Ameziani","year":"2020","journal-title":"Protein J."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111624","article-title":"Surface modification of polyurethane with eptifibatide-loaded degradable nanoparticles reducing risk of blood coagulation","volume":"201","author":"Reczy\u0144ska","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0680","doi-asserted-by":"crossref","first-page":"8316","DOI":"10.1038\/s41598-019-44767-2","article-title":"RGD-independent binding of Russell's viper venom kunitz-type protease inhibitors to platelet GPIIb\/IIIa receptor","volume":"9","author":"Kalita","year":"2019","journal-title":"Sci. Rep."},{"issue":"25","key":"10.1016\/j.ijbiomac.2021.10.015_bb0685","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.10.015_bb0690","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.chembiol.2009.08.012","article-title":"The platelet integrin \u03b1IIb\u03b23 binds to the RGD and AGD motifs in fibrinogen","volume":"16","author":"S\u00e1nchez-Cort\u00e9s","year":"2009","journal-title":"Chem. Biol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.10.015_bb0695","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/ATVBAHA.116.308604","article-title":"Trowaglerix venom polypeptides as a novel antithrombotic agent by targeting immunoglobulin-like domains of glycoprotein VI in platelet","volume":"37","author":"Chang","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0700","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.toxicon.2012.03.018","article-title":"Batroxase, a new metalloproteinase from B. atrox snake venom with strong fibrinolytic activity","volume":"60","author":"Cintra","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0705","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.toxicon.2015.11.002","article-title":"Evaluation of the in vivo thrombolytic activity of a metalloprotease from Bothrops atrox venom using a model of venous thrombosis","volume":"109","author":"Jacob-Ferreira","year":"2016","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0710","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00204-012-0914-3","article-title":"Isolation and characterization of two new non-hemorrhagic metalloproteinases with fibrinogenolytic activity from the mapanare (Bothrops colombiensis) venom","volume":"87","author":"Gir\u00f3n","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.10.015_bb0715","first-page":"542","article-title":"A novel fibrinolytic metalloproteinase, barnettlysin-I from Bothrops barnetti (Barnett s pitviper) snake venom with anti-platelet properties","volume":"1860","author":"Sanchez","year":"2016"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0720","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jprot.2013.01.021","article-title":"Proteomic analysis of Bothrops pirajai snake venom and characterization of BpirMP, a new PI metalloproteinase","volume":"80","author":"Bernardes","year":"2013","journal-title":"J. Proteome"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.10.015_bb0725","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11239-009-0379-2","article-title":"Anti-coagulant activity of a metalloprotease: further characterization from the indian cobra (Naja naja) venom","volume":"29","author":"Kumar","year":"2010","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0730","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.toxicon.2016.09.017","article-title":"Agkihpin, a novel SVTLE from Gloydius halys Pallas, promotes platelet aggregation in vitro and inhibits thrombus formation in vivo in murine models of thrombosis","volume":"122","author":"Xie","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0735","article-title":"Thrombolytic and antiplatelet effects of a novel plasminogen activator from the venom of Gloydius brevicaudus viper","volume":"27649","author":"Zhang","year":"2015","journal-title":"J. Atheroscler. Thromb."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0740","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pep.2013.07.009","article-title":"Expression, purification and characterization of recombinant plasminogen activator from Gloydius brevicaudus venom in Escherichia coli","volume":"91","author":"Zhang","year":"2013","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0745","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-1471-18","article-title":"Functional and biological insights of rCollinein-1, a recombinant serine protease from Crotalus durissus collilineatus","volume":"25","author":"Boldrini-Fran\u00e7a","year":"2019","journal-title":"J. Venomous Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0750","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.toxicon.2017.01.023","article-title":"Acute and repeated dose (28 days) toxicity studies in rats and dogs of recombinant batroxobin, a snake venom thrombin-like enzyme expressed from Pichia pastoris","volume":"129","author":"Kim","year":"2017","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0755","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10529-017-2441-z","article-title":"Cloning, expression, purification and bioactivity evaluation of a thrombin-like enzyme from Deinagkistrodon acutus venom gland library","volume":"40","author":"Li","year":"2018","journal-title":"Biotechnol. Lett."},{"issue":"13","key":"10.1016\/j.ijbiomac.2021.10.015_bb0760","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1073\/pnas.89.13.6040","article-title":"Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin","volume":"89","author":"Kelly","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb0765","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0049-3848(93)90195-T","article-title":"The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal models","volume":"71","author":"Bacher","year":"1993","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb0770","first-page":"596","article-title":"Human neutrophil peptide-1 inhibits thrombus formation under arterial flow via its terminal free cysteine thiols","volume":"17","author":"McDaniel","year":"2019"},{"issue":"5\u20136","key":"10.1016\/j.ijbiomac.2021.10.015_bb0775","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1159\/000083850","article-title":"Peptidomimetic thrombin inhibitors","volume":"33","author":"Kikelj","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0780","first-page":"291","article-title":"Vipegitide: a folded peptidomimetic partial antagonist of \u03b12\u03b21 integrin with antiplatelet aggregation activity","volume":"9","author":"Momic","year":"2015","journal-title":"Drug Des. Develop. Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.10.015_bb0785","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ddr.21407","article-title":"Peptide mimetic drugs for modulating thrombosis and hemostasis","volume":"78","author":"Nellenbach","year":"2017","journal-title":"Drug Dev. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0790","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/jth.14646","article-title":"Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a)","volume":"18","author":"Pasternack","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0795","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2018-02-769026","article-title":"Activated protein C, protease activated receptor 1, and neuroprotection","volume":"132","author":"Griffin","year":"2018","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.10.015_bb0800","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/blood.2019002771","article-title":"The protein C activator AB002 rapidly interrupts thrombus development in baboons","volume":"135","author":"Tucker","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0805","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jth.12797","article-title":"Fasxiator, a novel factor XIa inhibitor from snake venom, and its site-specific mutagenesis to improve potency and selectivity","volume":"13","author":"Chen","year":"2015","journal-title":"J. Thromb. Haemos."},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.10.015_bb0810","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10080321","article-title":"Recombinant and chimeric disintegrins in preclinical research","volume":"10","author":"David","year":"2018","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0815","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11239-007-0017-9","article-title":"Razaxaban, a direct factor xa inhibitor, in combination with aspirin and\/or clopidogrel improves low-dose antithrombotic activity without enhancing bleeding liability in rabbits","volume":"24","author":"Wong","year":"2007","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0820","first-page":"1","article-title":"An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy","volume":"300","author":"Huang","year":"2019"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.10.015_bb0825","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051008","article-title":"Nanotechnological strategies for protein delivery","volume":"23","author":"Villegas","year":"2018","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.10.015_bb0830","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12070426","article-title":"Improved antithrombotic activity and diminished bleeding side effect of a PEGylated alphaIIbbeta3 antagonist, disintegrin","volume":"12","author":"Kuo","year":"2020","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0835","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/10717544.2014.909908","article-title":"pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation","volume":"23","author":"Fan","year":"2016","journal-title":"Drug Deliv."},{"issue":"Pt A","key":"10.1016\/j.ijbiomac.2021.10.015_bb0840","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120200","article-title":"Emerging nanotherapeutics for antithrombotic treatment","volume":"255","author":"Zhao","year":"2020","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0850","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jemermed.2019.10.011","article-title":"Current strategies for the management of bleeding associated with direct oral anticoagulants and a review of investigational reversal agents","volume":"58","author":"Kaide","year":"2020","journal-title":"J.Emerg. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.10.015_bb0855","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s40264-018-0668-9","article-title":"Non-bleeding adverse events with the use of direct oral anticoagulants: a sequence symmetry analysis","volume":"41","author":"Maura","year":"2018","journal-title":"Drug Saf."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0860","doi-asserted-by":"crossref","first-page":"100009","DOI":"10.1016\/j.tru.2020.100009","article-title":"Intervention in COVID-19 linked hypercoaguable states characterized by circuit thrombosis utilizing a direct thrombin inhibitor","volume":"1","author":"Seshadri","year":"2020","journal-title":"Thromb. Update"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0865","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/17474086.2021.1875813","article-title":"Complement activation and coagulopathy-an ominous duo in COVID19","volume":"14","author":"Tomo","year":"2021","journal-title":"Expert. Rev. Hematol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.10.015_bb0870","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1740774520939871","article-title":"Clinical trials in the time of a pandemic","volume":"17","author":"Ellenberg","year":"2020","journal-title":"Clin. Trials"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0875","series-title":"Heparin-a century of progress","first-page":"211","article-title":"Adverse effects of heparin","author":"Alban","year":"2012"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.10.015_bb0880","first-page":"187","article-title":"Platelet glycoprotein IIb\/IIIa inhibition and its clinical use","volume":"2","author":"Huang","year":"2004"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0885","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/1076029609355589","article-title":"Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist","volume":"16","author":"Mousa","year":"2010","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0890","first-page":"272","article-title":"Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19","volume":"97","author":"Tedeschi","year":"2021","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb0895","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ahj.2014.06.017","article-title":"Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRACER)","volume":"168","author":"Jones","year":"2014","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb0900","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/2000656X.2020.1756836","article-title":"Effect of dipyridamole on random pattern skin flap viability in rats","volume":"54","author":"Uslu","year":"2020","journal-title":"J. Plastic Surg. Hand Surg."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.10.015_bb0905","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.apsb.2020.04.008","article-title":"Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19","volume":"10","author":"Liu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.10.015_bb0910","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/jth.14828","article-title":"Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series","volume":"18","author":"Wang","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0915","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11239-020-02208-2","article-title":"Successful use of tPA for thrombolysis in COVID related ARDS: a case series","volume":"51","author":"Goyal","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0920","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.amjcard.2020.06.039","article-title":"Considerations for management of acute coronary syndromes during the SARS-CoV-2 (COVID-19) pandemic","volume":"131","author":"Briedis","year":"2020","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.10.015_bb0925","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.radcr.2021.03.038","article-title":"Successful vascular interventional management of superior mesenteric vein thrombosis in a patient with COVID-19: a case report and review of literature","volume":"16","author":"Ebrahiminik","year":"2021","journal-title":"Radiol. Case Rep."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0930","series-title":"Seminars in thrombosis and hemostasis","article-title":"Pulmonary thrombosis in COVID-19 treated by thrombolysis: a small case series using streptokinase","author":"L\u00f3pez","year":"2020"},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.10.015_bb0935","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/jamaneurol.2020.2396","article-title":"Stroke thrombolysis with tenecteplase to reduce emergency department spread of coronavirus disease 2019 and shortages of alteplase","volume":"77","author":"Warach","year":"2020","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.10.015_bb0940","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.toxicon.2010.02.031","article-title":"Isolation and functional characterization of a new acidic PLA2 Ba SpII RP4 of the Bothrops alternatus snake venom from Argentina","volume":"56","author":"Garcia Denegri","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0945","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.toxicon.2018.07.014","article-title":"The Kv1.3 channel-inhibitory toxin BF9 also displays anticoagulant activity via inhibition of factor XIa","volume":"152","author":"Ding","year":"2018","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.10.015_bb0950","first-page":"290","article-title":"Purification and functional characterization of a new metalloproteinase (BleucMP) from Bothrops leucurus snake venom, comparative biochemistry and physiology","volume":"153","author":"Gomes","year":"2011","journal-title":"Toxicol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0955","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/673941","article-title":"Bmoo FIBMP-I: a new fibrinogenolytic metalloproteinase from Bothrops moojeni snake venom","volume":"2012","author":"Torres","year":"2012","journal-title":"ISRN Toxicol."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0960","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.toxicon.2016.01.055","article-title":"Biochemical and functional characterization of BmooSP, a new serine protease from Bothrops moojeni snake venom","volume":"111","author":"de Oliveira","year":"2016","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0965","first-page":"102","article-title":"Biochemical and enzymatic characterization of BpMP-I, a fibrinogenolytic metalloproteinase isolated from bothropoides pauloensis snake venom","volume":"161","author":"Naves de Souza","year":"2012"},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.10.015_bb0970","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s10930-010-9273-1","article-title":"CCSV-MPase, a novel procoagulant metalloproteinase from Cerastes cerastes venom: purification, biochemical characterization and protein identification","volume":"29","author":"Cherifi","year":"2010","journal-title":"Protein J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0975","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12038-011-9068-3","article-title":"Fibrinogenolytic toxin from indian monocled cobra (Naja kaouthia) venom","volume":"36","author":"Sekhar","year":"2011","journal-title":"J. Biosci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.10.015_bb0980","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.toxicon.2012.06.010","article-title":"LmrTX, a basic PLA2 (D49) purified from Lachesis muta rhombeata snake venom with enzymatic-related antithrombotic and anticoagulant activity","volume":"60","author":"Damico","year":"2012","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb0985","first-page":"111","article-title":"Malabarase, a serine protease with anticoagulant activity from Trimeresurus malabaricus venom","volume":"164","author":"Kumar","year":"2013"},{"issue":"17","key":"10.1016\/j.ijbiomac.2021.10.015_bb0990","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174088","article-title":"Isolation of a novel metalloproteinase from agkistrodon venom and its antithrombotic activity analysis","volume":"20","author":"Huang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb0995","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.abb.2015.11.006","article-title":"Thrombolytic protein from cobra venom with anti-adhesive properties","volume":"590","author":"Chanda","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb1000","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.toxicon.2015.12.017","article-title":"Characterization and structural analysis of a potent anticoagulant phospholipase A2 from Pseudechis australis snake venom","volume":"111","author":"Du","year":"2016","journal-title":"Toxicon"},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.10.015_bb1005","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21945","article-title":"Purification and partial characterization of an anticoagulant PLA2 from the venom of indian Daboia russelii that induces inflammation through upregulation of proinflammatory mediators","volume":"31","author":"Deka","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.10.015_bb1010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086823","article-title":"The pro-coagulant fibrinogenolytic serine protease isoenzymes purified from Daboia russelii russelii venom coagulate the blood through factor V activation: role of glycosylation on enzymatic activity","volume":"9","author":"Mukherjee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111527","article-title":"Antithrombotic and anticoagulant effects of a novel protein isolated from the venom of the Deinagkistrodon acutus snake","volume":"138","author":"Huang","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb1020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.biochi.2012.10.013","article-title":"Purification and characterization of AHPM, a novel non-hemorrhagic P-IIIc metalloproteinase with alpha-fibrinogenolytic and platelet aggregation-inhibition activities, from Agkistrodon halys pallas venom","volume":"95","author":"Song","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb1025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40409-017-0126-7","article-title":"BaltDC: purification, characterization and infrared spectroscopy of an antiplatelet DC protein isolated from Bothrops alternatus snake venom","volume":"23","author":"Matias","year":"2017","journal-title":"J. Venomous Anim. Toxins Incl. Trop. Dis."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.10.015_bb1030","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2174\/0929866525666181004101622","article-title":"BaltPLA2: a new phospholipase A2 from Bothrops alternatus Snake venom with antiplatelet aggregation activity","volume":"25","author":"Dias","year":"2018","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb1035","article-title":"Purification and characterization of BmooAi: a new toxin from Bothrops moojeni snake venom that inhibits platelet aggregation","volume":"2014","author":"de Queiroz","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb1040","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/352420","article-title":"Rapid purification of a new P-I class metalloproteinase from Bothrops moojeni venom with antiplatelet activity","volume":"2014","author":"de Queiroz","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb1045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jpba.2012.04.008","article-title":"Isolation and expression of a hypotensive and anti-platelet acidic phospholipase A2 from Bothrops moojeni snake venom","volume":"73","author":"Silveira","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.10.015_bb1050","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00204-011-0665-6","article-title":"Molecular characterization of an acidic phospholipase A2 from Bothrops pirajai snake venom: synthetic C-terminal peptide identifies its antiplatelet region","volume":"85","author":"Teixeira","year":"2011","journal-title":"Arch. Toxicol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.10.015_bb1055","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.3390\/toxins5122403","article-title":"Molecular cloning and pharmacological properties of an acidic PLA2 from Bothrops pauloensis snake venom","volume":"5","author":"Ferreira","year":"2013","journal-title":"Toxins"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.10.015_bb1060","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21885","article-title":"Purification and characterization of a platelet aggregation inhibitor and anticoagulant cc 5_NTase, CD 73-like, from Cerastes cerastes venom","volume":"31","author":"Saoud","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.10.015_bb1065","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2174\/0929866527666200813200148","article-title":"Isolation and characterization of CD39-like phosphodiesterase (Cc-PDE) from Cerastes cerastes venom: molecular inhibitory mechanism of antiaggregation and anticoagulation","volume":"28","author":"Kiheli","year":"2021","journal-title":"Protein Pept. Lett."},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.10.015_bb1070","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/toxins10080332","article-title":"Purification and characterization of a novel antiplatelet peptide from Deinagkistrodon acutus venom","volume":"10","author":"Kong","year":"2018","journal-title":"Toxins"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.10.015_bb1075","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.toxicon.2011.01.010","article-title":"A novel platelet glycoprotein ib-binding protein with human platelet aggregation-inhibiting activity from Trimeresurus jerdonii venom","volume":"57","author":"Chen","year":"2011","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.10.015_bb1080","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bbrc.2013.10.125","article-title":"Anti-platelet activity of a three-finger toxin (3FTx) from indian monocled cobra (Naja kaouthia) venom","volume":"441","author":"Chanda","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.10.015_bb1085","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00277-010-1103-1","article-title":"The metalloprotease, NN-PF3 from Naja naja venom inhibits platelet aggregation primarily by affecting \u03b12\u03b21 integrin","volume":"90","author":"Kumar","year":"2011","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb1090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.toxicon.2012.12.025","article-title":"cDNA cloning of a snake venom metalloproteinase from the eastern diamondback rattlesnake (Crotalus adamanteus), and the expression of its disintegrin domain with anti-platelet effects","volume":"64","author":"Suntravat","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb1095","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ijbiomac.2018.01.038","article-title":"First report of the characterization of a snake venom apyrase (Ruviapyrase) from indian Russell's viper (Daboia russelii) venom","volume":"111","author":"Kalita","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb1100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.toxicon.2015.06.010","article-title":"Purification and characterization of two high molecular mass snake venom metalloproteinases (P-III SVMPs), named SV-PAD-2 and HR-Ele-1, from the venom of Protobothrops elegans (Sakishima-habu)","volume":"103","author":"Oyama","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb1105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cbpa.2016.01.021","article-title":"BbrzSP-32, the first serine protease isolated from Bothrops brazili venom: purification and characterization","volume":"195","author":"Zaqueo","year":"2016","journal-title":"Comp. Biochem. Physiol. A Mol. Integr. Physiol."},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb1110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.taap.2018.08.018","article-title":"BjSP, a novel serine protease from Bothrops jararaca snake venom that degrades fibrinogen without forming fibrin clots","volume":"357","author":"Carone","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.10.015_bb1115","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/j.biochi.2012.07.007","article-title":"Biochemical characterization and comparative analysis of two distinct serine proteases from Bothrops pirajai snake venom","volume":"94","author":"Menaldo","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2021.10.015_bb1120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.toxicon.2013.04.004","article-title":"Primary structure and characterization of a non hemorrhagic metalloproteinase with fibrinolytic activity, from the snake venom of Protobothrops tokarensis (Tokara-habu)","volume":"70","author":"Oyama","year":"2013","journal-title":"Toxicon"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021021565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021021565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:16:51Z","timestamp":1758878211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813021021565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":224,"alternative-id":["S0141813021021565"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.10.015","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}